CXCL16 and leukemia: CXCL16 dramatically increased the percentage of Th17 cells in the BM, spleen, LNs and PB (Fig. 7f, g and Supplementary Fig. 6b), indicating that CXCL16 promotes the migration of Th17 cells to the leukemia niche in vivo.